“High performance computing technology plays a critical role in modern viral research, deepening our understanding of how specific viruses work and ultimately accelerating the development of potential therapeutics and vaccines,” said Lisa Su, president and CEO, AMD. “AMD and our technology partners are proud to provide researchers around the world with these new systems that will increase the computing capability available to fight COVID-19 and support future medical research.”
The recipient universities are expected to utilize the new compute capacity across a range of pandemic-related workloads including genomics, vaccine development, transmission science and modeling. Additionally, scientists from around the world conducting COVID-19 research can request access to the remote AMD-powered cloud HPC cluster at Penguin Computing by submitting proposals to COVID-19HPC@amd.com.